T1	Participants 436 631	Premenstrual women with laparoscopically diagnosed endometriosis who required GnRH agonist therapy for treatment and did not have significant depressive or premenstrual mood symptoms at baseline.
T2	Participants 648 748	Participants were randomly assigned to either the sertraline treatment group or to the placebo group
